RecruitingNCT05683184
PET imaging of CB1 receptors in people with opioid use disorder and healthy adults
Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
The study compares people with opioid use disorder and healthy volunteers using PET brain imaging with the radiotracer [11C]OMAR. The registry does not specify the number or timing of scans in the fields reviewed.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 10, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05683184
- Official title
Show the full official title
Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including [11C]OMAR.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
